Mayfex

Quick links to important sections

Mayfex

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mayfex

Property Description
Active ingredient Fexofenadine Hydrochloride
Form Oral Tablet, Oral Suspension
Pharmacological class Second-Generation Antihistamine
Common purpose Relief of allergic symptoms
Origin Synthetic metabolite

Mayfex is a modern oral medicine whose primary active ingredient is Fexofenadine Hydrochloride. It is formally classified as a Second-Generation Antihistamine and functions as a Selective H1 Receptor Antagonist, a mechanism clinically recognized for effectively mediating allergic responses. This classification confirms that Mayfex is a synthetic compound derived as an optimized metabolite; it is specifically designed to minimize the ability to cross the blood-brain barrier. Pharmacological studies support that this design provides the practical benefit of being a non-sedating option, enabling individuals to manage their seasonal allergy symptoms without impairment of daily alertness.

What is the Active Ingredient and Physical Form of Mayfex?

The product's efficacy is driven by Fexofenadine Hydrochloride, intended for systemic delivery via the Oral Route. It is manufactured in common Dosage Forms, primarily as an Oral Tablet and an Oral Suspension. The inclusion of the liquid Oral Suspension form is a strategic feature that allows for appropriate administration to a broad Target Audience, specifically addressing the needs of children and those with swallowing difficulties. While Mayfex is typically supplied as a Single-Ingredient Product, its availability also extends to a Fixed-Dose Combination Product, Mayfex M, which incorporates an additional compound for enhanced symptomatic control.

What is the General Purpose of Taking Mayfex?

The general purpose of Mayfex is to provide targeted relief by mitigating the physical symptoms caused by the body's over-reaction to common allergens, such as those that trigger Seasonal Allergic Rhinitis. Its mechanism of histamine inhibition effectively counteracts the chemical cascade that leads to typical discomforts like itching, sneezing, and runny nose. By offering a long-acting, non-sedating profile, Mayfex provides the general benefit of sustaining patient comfort throughout the day, which is essential for maintaining consistent function during peak allergy seasons.

Regulatory References

  1. MedlinePlus Fexofenadine Information

What side effects are possible with Mayfex?

Possible side effects and safety information

Adverse reactions associated with Mayfex (Fexofenadine Hydrochloride) are officially documented by frequency and the physiological systems affected. These classifications reflect how regulatory bodies organize and communicate the medicine’s safety profile, based on data from clinical trials and post-marketing surveillance.

Frequency-Classified Adverse Reactions

Adverse effects are categorized by frequency of occurrence observed in regulatory studies:

  • Common (occurring in up to 1 in 10 patients): These include reactions such as headache, somnolence (drowsiness), dizziness, and nausea.
  • Uncommon: Fatigue has been officially listed in this category.
  • Not Known (frequency cannot be estimated): This tier, often based on post-marketing reports, includes reactions like insomnia, nervousness, sleep disorders, palpitations, tachycardia, diarrhea, rash, pruritus (itching), and urticaria (hives).

System-Organ Classes and Serious Safety Concerns

The documented adverse effects span multiple System-Organ Classes, including Nervous System Disorders (headache, dizziness), Gastrointestinal Disorders (nausea, diarrhea), Psychiatric Disorders (insomnia, nervousness), and Cardiac Disorders (palpitations, rapid heartbeat).

Serious Adverse Reactions officially noted include immediate Hypersensitivity Reactions such as Anaphylaxis and Angioedema (swelling beneath the skin). Mayfex is formally contraindicated in individuals with a known hypersensitivity to the active substance or any of its components.

Safety Considerations for Specific Populations

Regulatory documents highlight the need for caution in certain populations. Individuals with Renal or Hepatic Impairment may require particular attention because fexofenadine is primarily eliminated via the renal and biliary routes, which could prolong its presence in the body. Older adults are also noted as a population where caution is appropriate, often due to age-related decline in kidney function.

Overdose and Emergency Response

The official regulatory profile for a Mayfex overdose is based on documented clinical experience and specific high-dose studies. The documented manifestations reported in cases of overdosage are generally non-severe and involve central nervous system and oral effects. These include the clinical signs of dizziness, drowsiness (or somnolence), and fatigue, alongside the symptom of dry mouth. While clinical studies of single high doses up to 800 mg did not result in major adverse events, the maximum tolerated dose remains unestablished in regulatory records.

Upon any suspected overdosage, the mandatory regulatory guidance is to seek immediate medical attention. This action is essential for initiating management, as no specific antidote is known for Mayfex. Treatment is strictly limited to symptomatic and supportive treatment, meaning care is provided to address the clinical signs as they occur.

Supportive measures considered by professionals may include standard procedures to remove any unabsorbed medicinal product. Regulatory documents specifically note that haemodialysis does not effectively remove the active substance from the blood, guiding subsequent clinical intervention.

Therapeutic Uses of Mayfex

What Mayfex Treats: Main Uses and Benefits

Mayfex is considered relevant within the therapeutic domain of allergic rhinitis. It is applied in situations involving certain distressing symptoms related to heightened physiological activity and irritative states.

Symptom Management and Functional Support

Mayfex is considered relevant for conditions presenting with systemic or localized discomfort, applicable in situations involving recurrent or episodic manifestations like Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, and Chronic Idiopathic Urticaria (hives). It may assist with easing symptoms related to inflammatory or irritative states, addressing symptom clusters that may become intense or disruptive, such as sneezing, runny nose (rhinorrhea), and pruritus (itching) of the skin or eyes.

This is relevant when supportive symptom management is appropriate in scenarios where functional stability becomes affected, especially when symptoms interfere with daily functioning. It assists with maintaining functional stability during periods of symptoms that interfere with routine activities, contributing to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Allergic Discomfort Mayfex is commonly used when short-term symptomatic assistance is needed to address both nasal/ocular allergy symptoms and skin hives/itching, assisting with maintaining functional stability when symptoms become more noticeable.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

The eligibility for Mayfex (Fexofenadine Hydrochloride) is officially determined by age and the patient’s existing medical conditions, according to governmental regulatory documents.

Contraindications and Restrictions

  • Contraindication: Mayfex is contraindicated in patients with a known hypersensitivity (allergy) to fexofenadine hydrochloride or any other ingredient in the medicine.
  • Restricted Use (Renal Impairment): Patients with decreased renal (kidney) function require conditional use. Regulatory labeling requires a specific starting dose reduction for those with moderate to severe renal impairment.
  • Conditional Use (Cardiovascular): Use with caution is advised for patients with a history of cardiovascular disease.

Age-Related Eligibility

Age Group Eligibility Status (as per official labels)
Adults and Adolescents (ge 12 years) Approved for use.
Children (6-11 years) Approved for use.
Infants (< 6 months) Safety and efficacy are not established for any indication.

Pregnancy and Lactation

Official labeling states that use during pregnancy is not recommended unless the potential benefit outweighs the risk, due to insufficient data. Use is also not recommended or advised with caution during breastfeeding, as the drug may pass into breast milk.

What should I know about interactions with other medicines?

Mayfex Interactions with other medicines and products

Official regulatory documents describe specific interactions that may alter the exposure of Mayfex (fexofenadine) or affect its use with certain products.

Interactions with Specific Medicines

  • Aluminum and Magnesium Hydroxide Antacids: Co-administration with antacids containing aluminum or magnesium is identified in official labeling as causing a decrease in the exposure of Mayfex. A clear timing separation is required for these products to avoid this interaction.
  • P-glycoprotein Inhibitors: Concomitant use with strong inhibitors of the P-glycoprotein transporter (e.g., erythromycin, ketoconazole) is documented to increase Mayfex plasma concentration levels (AUC and C max). These combinations should be used with caution.

Non-Medicinal Interactions

  • Fruit Juices: The official regulatory information states that Mayfex should not be taken with fruit juices, including grapefruit, orange, or apple juice. This is associated with a decrease in the amount of Mayfex absorbed into the bloodstream.

Population-Specific Considerations

  • Renal Impairment: Patients with reduced kidney function may experience increased exposure to Mayfex. The official label advises consultation in this population to address the altered clearance and potential need for monitoring.

Mechanism of Action

How Mayfex Works

Mayfex operates primarily as an antagonist at the Histamine H1-receptor, a protein located on cells in peripheral tissues, including the endothelium and smooth muscle. The drug binds selectively to this receptor, preventing the endogenous chemical messenger, histamine, from initiating its signaling cascade. This interaction modulates pathways associated with histamine release.

The drug's chemical structure dictates a low affinity for the central nervous system, which results in its activity being concentrated in peripheral systems outside of the brain. It largely avoids engaging central H1-receptors. By blocking peripheral H1-receptors, Mayfex modifies the downstream molecular steps that typically lead to increased capillary permeability and smooth muscle contraction. This mechanism causes predictable physiologic adjustments by limiting tissue changes and modifying the effects of mediator activity in localized areas.

Dosage and Administration Information

How to Use Mayfex

The principles governing the use of Mayfex (Fexofenadine Hydrochloride) focus on the approved route, standard dose ranges, and necessary patient administration instructions. The medicine is approved for the Oral Route of administration, available in forms including tablets and oral suspension.

Official Dosing and Administration

The standard dose and frequency are dictated by the patient's age and clinical scenario. For adults and children 12 years of age and older, the typical regimen is 180 mg once daily or 60 mg twice daily. For children aged 6 to 11 years, the established dose is 30 mg twice daily.

Specific administration rules must be followed to ensure proper absorption and bioavailability:

Feature Official Labeled Instruction
Dose Adjustment for Renal Impairment Adults (aged 12 years and older) with decreased kidney function should start with 60 mg once daily. Children (6–11 years) in this group should use 30 mg once daily.
Timing with Beverages Must be taken with water. Administration with grapefruit, apple, or orange juice is restricted as it may affect absorption.
Antacid Separation Separate administration from antacids containing aluminum or magnesium by at least 2 hours.

Usage Protocol

The core usage protocol is defined by the Standardized Dosing Schedule and specific Contextual Administration Requirements. The once-daily or twice-daily frequency defines the long-term use pattern for the duration of the symptomatic period. If a scheduled dose is missed, it should be skipped entirely, and the patient should resume the regular dosing schedule; it is recommended not to double the next dose to compensate.

Recent Clinical Evidence

Mayfex: Recent Clinical Evidence


Phase I and II Trials: Safety and Preliminary Observations

Initial studies focused on the drug’s relationship with inflammatory processes, as defined in the study protocols, across a small group of participants. These early trials aimed to determine the maximum tolerated dose and characterize the drug’s safety profile.

Clinical trials evaluated changes in measured outcomes, such as pain scores, in study participants and examined metrics related to the onset of observed changes. The trials examined the drug's safety profile, with researchers noting the incidence of signs of liver dysfunction in the study population.


Phase III Trials: Efficacy and Long-term Data

Subsequent Phase III studies further evaluated the drug's effect in a much larger patient population. These studies measured the change in a validated symptom severity scale from baseline.

  • Primary Findings: The study findings indicated differences in measured scores between the drug group and the placebo group. Researchers recorded and reported the incidence and severity of adverse events.
  • Long-term Data: Follow-up studies, some lasting up to a year, extended the observation period. The full trial results, published in 20XX, included observations where researchers recorded changes in symptom severity metrics during the 12-month observation period, along with continued monitoring of the safety profile.

Study Populations and Dosing Protocols

Dosing protocols in the studies were structured according to the study design, often involving adjustments based on predefined criteria. Research protocols considered participant characteristics; for example, the studied populations did not include participants with severe renal impairment.

Ongoing Research

Research continues to evaluate the drug's potential applications in the management of other inflammatory conditions, with initial small-scale studies suggesting differences in inflammatory marker values. It is not yet clear whether these preliminary findings will be confirmed in larger trials.

Frequently Asked Questions (FAQ)

Common questions about Mayfex (FAQ)


Q: How quickly does Mayfex typically start working?

Studies and official information indicate that the medicine's main effect generally begins to be observed within 1 hour after administration. The maximum effect is generally observed within 2 to 3 hours after administration.


Q: How long can I expect the effects of Mayfex to last?

Regulatory documents indicate that a significant antihistamine effect was sustained for 12 hours following a single dose in clinical studies. This longer duration of action is supported by the drug's elimination half-life, which is approximately 14.4 hours.


Q: What foods or supplements are noted to interact with Mayfex?

Official labeling states that Mayfex should not be taken with grapefruit, apple, or orange juice. Regulatory information indicates that these beverages may affect the amount of medicine absorbed. Additionally, regulatory reviews have noted that certain supplements, such as St. John’s Wort, may also affect its absorption.


Q: Is Mayfex generally appropriate for use in older adults?

Official labeling advises caution when Mayfex is used in older adults. This attention is primarily due to the increased possibility of age-related decline in kidney function, which can affect how the body clears the medicine. Specific usage considerations are addressed by a healthcare provider.


Q: What is the general level of evidence supporting Mayfex's use?

Mayfex (Fexofenadine) is widely recognized and classified as a Second-Generation Antihistamine. Reflecting the established role of the drug, it is included on the World Health Organization's List of Essential Medicines, which recognizes medications considered important for basic public health systems.


Q: Why do official sources sometimes use the name 'Mayfex' and sometimes the chemical name?

Official documents often use the name Mayfex to refer to the specific brand-marketed product. The name Fexofenadine Hydrochloride is used to identify the active pharmacological ingredient, which is the chemical component responsible for the medicine's effect.


Q: Is Mayfex safe to use for an extended period?

Clinical trials for Mayfex have included continuous monitoring for up to one year. Official health bodies state that the medicine's profile suggests it is generally well-tolerated when taken for a long time, but use should be guided by symptomatic need.


Q: How does the effectiveness of Mayfex relate to its dosage, generally speaking?

Regulatory documents indicate that official dosing regimens are specifically established to reach drug plasma levels necessary for an appropriate antihistamine effect. The approved doses correspond to the range shown in clinical trials to be associated with a reduction in allergic symptom scores.


Q: Is Mayfex available in different strengths?

Yes, according to official product information, Mayfex (Fexofenadine) is available in several strengths for oral use. These include 30 mg, 60 mg, and 180 mg tablets, and it is also available as an oral suspension for liquid administration.


Q: Is there any information about Mayfex and driving or operating machinery?

Although Mayfex is classified as non-drowsy, drowsiness (somnolence) is listed as a common side effect in official documents. Regulatory advice notes that individuals should be aware of how the drug may affect them before engaging in activities like driving or operating machinery.


Q: Is Mayfex known to cause weight changes?

According to official regulatory documents, neither weight gain nor weight loss is listed among the common, uncommon, or unknown adverse reactions reported in clinical trials or post-marketing surveillance.


Q: Is it normal to feel a change in appetite while on Mayfex?

Changes in appetite are not listed in the official regulatory documents among the reported adverse reactions observed in clinical trials or post-marketing surveillance.


Q: Can Mayfex be taken alongside common pain relievers?

General official guidance indicates that Mayfex may typically be taken alongside common pain relievers such as paracetamol or ibuprofen. However, the co-administration of any medications requires professional review.


Q: Is there a known interaction between Mayfex and alcohol?

Official labeling does not formally state a direct interaction between Mayfex and alcohol. However, since the medicine can cause side effects like drowsiness or dizziness, consuming alcohol may increase the risk of experiencing these effects.


Q: Is Mayfex described as having a Black Box Warning in the U.S.?

No, Mayfex (Fexofenadine) does not carry a Black Box Warning from the U.S. FDA. This type of warning is reserved for serious adverse effects and is not associated with this medication.


Q: Is Mayfex considered a controlled substance?

No, Mayfex (Fexofenadine) is not classified as a controlled substance under the U.S. Drug Enforcement Administration (DEA) or similar international agencies.


Q: Do I need to avoid sun exposure while using Mayfex?

The need to avoid sun exposure or photosensitivity is not listed as a contraindication or warning in the official regulatory documents for Mayfex.


Q: Can Mayfex interact with herbal remedies like St. John's Wort?

Official regulatory reviews have indicated that certain herbal supplements, such as St. John's Wort, may interact with Mayfex by potentially altering how the body absorbs it. Official reviews note that co-administration may require professional consideration due to limited extensive data.


Q: Is it necessary to have routine testing done while using Mayfex?

Official regulatory documents do not require mandatory routine laboratory testing, such as blood work, for typical use of Mayfex. However, monitoring may be required for individuals who have pre-existing kidney or liver issues.


Q: Does Mayfex contain lactose or gluten?

The inactive ingredients (excipients) in certain Mayfex tablet formulations are listed and include lactose (lactose monohydrate). Information from official sources indicates that gluten is not listed as an ingredient in these formulations.


Q: What should I do if I accidentally take too much Mayfex?

The official product label describes the need for immediate medical attention in the event of an overdose. You should also contact a Poison Control Center for guidance.


Q: Are there any reported cases of dependence or withdrawal from Mayfex?

Mayfex is not associated with reports of physical dependence. Clinical reviews suggest that true withdrawal symptoms are not widely recognized when the medicine is stopped, though original allergy symptoms may return.


Q: What if Mayfex seems to stop working after a while?

Regulatory data from clinical studies found no evidence of tolerance to the antihistamine effects over the 28-day dosing period examined. Loss of efficacy over time is not a formally listed regulatory warning.


Q: Are there different brand names for the same medicine as Mayfex?

Yes, Mayfex is a brand name for the active ingredient, fexofenadine. The medicine is also marketed under various other brand names in different regions around the world, such as Allegra or Telfast.


Q: Can Mayfex be used in conjunction with other medicines for the same condition?

Official guidance notes that it is generally acceptable to take Mayfex alongside other specific treatments for the same condition, such as steroid nasal sprays or eye drops. The use of combination treatments is subject to professional review.


Q: Does Mayfex require a special prescription or monitoring program?

No, official regulatory documentation indicates that Mayfex is not part of a special FDA safety program (REMS). It is available for use without requiring unique patient monitoring protocols.


Q: What are the official guidelines regarding stopping Mayfex use?

Official guidance indicates that Mayfex generally can be stopped abruptly without requiring a tapering period. However, official information indicates that allergy symptoms may return within one to three days after discontinuation.


Q: Is Mayfex a generic drug or a brand name drug?

Mayfex is a brand name product. However, the active ingredient, Fexofenadine Hydrochloride, is now also available in a wide range of official generic formulations from different manufacturers.


Q: Are changes in mood a possible side effect of Mayfex?

Official regulatory documents list side effects under the category of Psychiatric Disorders, which includes reports of insomnia and nervousness. Broader 'changes in mood' are not explicitly detailed in the official list of adverse reactions.

How should Mayfex be stored and disposed of?

How to Store and Dispose of Mayfex

All storage and disposal of Mayfex must strictly follow the conditions specified in the official regulatory labeling to ensure product quality and safety.

Storage Requirement Official Condition
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Container & Handling Tablets must be kept in the original blister packaging. The Oral Suspension bottle must be kept tightly closed and not frozen.
Safety Keep the medicine out of the sight and reach of children.

Disposal Instructions

Expired or unused Mayfex must be disposed of in accordance with local regulations. Regulatory guidance recommends using a community drug take-back program. If this is unavailable, the medicine should be mixed with an undesirable substance (e.g., used coffee grounds) and placed in a sealed container before discarding in the household trash. Do not flush Mayfex down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mayfex found in:

A-Z Index: